Hanmi Pharmaceutical

Roche pens $2.5B pact for Hanmi’s muscle-conserving obesity drug

Roche took its obesity strategy into uncharted territory via a $190 million upfront payment for a clinical-stage UCN2 analog from South Korea’s Hanmi.

James Waldron Aug 24, 2026 4:42am

Lilly's $1.2B deal for Hanmi GLP-2 drug for short bowel syndrome

Jun 1, 2026 3:52am

Aptose exits cancer pact after Hanmi buyout blocks development

May 14, 2026 6:35am

Glowing puzzle piece fitting into puzzle

Gilead pumps up virology pipeline with drug transporter deal

Sep 29, 2025 10:35am

Aptose to pay Hanmi up to $420M for myeloid inhibitor

Nov 4, 2021 10:37am

Hanmi's Type 2 diabetes drug curbs cardiovascular, kidney issues

Jun 28, 2021 5:19pm